Clinical Trials Browser

Withdrawn × INDUSTRY × navitoclax × Clear all

NCT01423539 2016-11-02

NAVIGATE

Phase 2 Withdrawn

Lymphoma, Large B-Cell, Diffuse

NCT00918450 2010-02-26

Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell